Al Altomari, Chairman and CEOAgile Therapeutics
Charlene Banard, Global Head of Technical Operations Cell & Gene Therapy Strategy, Innovation Pipeline and PMONovartis
Jeffrey Berkowitz, Board MemberH. Lundbeck A/S
Liz Bywater, Ph.D., PresidentBywater Consulting Group
Ron Cohen, M.D., President & CEOAcorda Therapeutics
Laurie Cooke, CEOHealthcare Businesswomen's Association (HBA)
John Crowley, Chairman and CEOAmicus Therapeutics
Rich Daly, Chief Operating OfficerBeyond Spring
Raúl Díaz, Animal Health Large Molecules Biopharm. OperationsMSD, Montes Claros, MG, Brazil
Tom Dilenge, President, Advocacy, Law & Public Policy DivisionBiotechnology Innovation Organization
Joseph Ferra, CFOSyros Pharmaceuticals
Anu Hans, VP, Strategic InitiativesJanssen Supply Chain
Fred Hassan, Managing DirectorWarburg Pincus
Paul Hastings, President and CEONkarta Therapeutics
Axel Hoos, M.D., Ph.D., SVP Oncology R&DGSK
John Hubbard, Ph.D., Emeritus Editorial Advisory Board MemberLife Science Leader
Mitchell Katz, Ph.D., Vice President, Development OperationsFerring Pharmaceutical, Inc.
Mary Rose Keller, VP, Clinical OperationsHeron Therapeutics
Rachel King, CEOGlycoMimetics
Suresh Kumar, Former EVP External AffairsSanofi
John LaMattina, Ph.D., Sr. PartnerPureTech Health
Jacks Lee, SVP global manufacturing and supplyMerck
Martin Lehr, CEOContext Therapeutics
Sandy Macrae, Ph.D., President & CEOSangamo Therapeutics
Ken Moch, Former President & CEOCognition Therapeutics
Carol Nacy, Ph.D., CEOSequella
Francois Nader, M.D., Chairman of the BoardAcceleron Pharma
Julia Owens, Ph.D., President and CEOMillendo Therapeutics
Sandra Poole, COOCandel Therapeutics
Dennis Purcell, Founder & Sr. AdvisorAisling Capital
David Pyott, Chairman of the BoardBioniz Therapeutics
Chandra Ramanathan, Ph.D., MBA, VP & Head, East Coast Innovation CenterBayer
Stephen Rapundalo, Ph.D., President & CEOMichBio
Pamela Reilly Contag, Ph.D., Cofounder and CEOBioEclipse Therapeutics
John Reynders, Ph.D., VP, R&D strategy, program management, and data sciencesAlexion
James Robinson, Emeritus Editorial Advisory Board MemberLife Science Leader
Tomasz Sablinski, M.D., Ph.D., co-founder and board memberTransparency Life Sciences
Jim Scibetta, CEOMaverick Therapeutics
Chhaya Shah, SVP Technical OperationsRadius Health
Allan Shaw, Independent Consultant
Brandi Simpson, Former President and CEONavigen
Andrew Skibo, Emeritus Editorial Advisory Board Member, Life Science LeaderMedImmune / AstraZeneca
Jason Urban, Ph.D., Sr. Dir. Quality Risk ManagementAlexion
Thomas Wiggans, Founder, CEO, ChairmanDermira
Leslie Williams, Entrepreneur, Executive, Board Member, MentorImmusanT
Tim Wright, CEOMiMedx
ASK THE BOARD
- What — If Any — “Silver Linings” Have You Observed Take Place At Your Company Resulting From The Chaos Caused By COVID-19?
- What Was Your Biggest Business Learning From The First Half Of 2020 And Why?
- What Is Your Biggest Concern Regarding Biopharma’s Reputation With The American People If We Do Not Have A COVID-19 Vaccine By The End Of 2020?
- What Is Your Biggest Concern Regarding The Biopharma Industry’s Reputation With The American People If We Don’t Have A COVID-19 Vaccine By The End Of This Year?
- What’s Your Perspective On The Rise Around Virtual Pitching To Investors, And What Will Be Its Impact On Annual Investor Meetings Like The Biotech Showcase And JPM In 2021?
- What — If Any — Silver Linings Have You Observed Taking Place At Your Company Resulting From The Chaos Caused By COVID-19?
IN THIS MONTH'S ISSUE
-
Election Fallout: Can Divided Government Forge Bipartisan Solutions?
As the election concludes, we still face new changes to healthcare policy, pharma price-controls, taxes, and a staggering debt.
-
The Role Of Failure In Innovation
Being an innovator is not for the faint of heart. Failure is a natural part of the innovation process, and you need to be comfortable with it and embrace it.
-
Life Sciences Dealmaking In The Time Of COVID-19
COVID-19 has impacted how both private and public companies and investors enter into financing transactions. This article examines some trends in the industry which have emerged during this unprecedented time for dealmaking.
-
Companies To Watch: Ridgeback Biotherapeutics
Ridgeback Biotherapeutics is pitting new and potent antivirals versus COVID, Ebola, and other coronaviruses.
-
The Road To Commercialization: Small Company Considerations
Planning and executing a product launch is a complex process that must be tailored to both the product and the market. Success requires strategic focus, cross-functional alignment, and an organizational framework capable of effective delivery
BEYOND THE PRINTED PAGE
@LIFESCILEADER1
EVENTS
-
BREXIT - What's Changing for Life Science Product License Holders-Manufacturers and What you Need to do Right Now
December 1, 2020
-
Physician Compensation Update: What Providers Need to Know
December 1, 2020
-
ATS Automation Virtual Expo 2020
December 2 - 3, 2020
-
HIPAA HITECH Changes 2021 - What's New?
December 2, 2020
-
Data Integrity: Compliance with 21 CFR Part 11, SaaS-Cloud, EU GDPR
December 3, 2020
This website uses cookies to ensure you get the best experience on our website. Learn more